Topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis

Future Rheumatology

Volumn 2, Issue 2, 2007, Pages 163-175

  Touma, Zahi ^a   Chen, Lan ^b   Arayssi, Thurayya ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diclofenac; Ibuprofen; Ketoprofen; Meta analysis; Osteoarthritis; Piroxicam; Randomized controlled trials; Topical nonsteroidal anti inflammatory drugs

Indexed keywords

3 SNAKE OIL; CAPSAICIN; CHINESE DRUG; CHONDROITIN SULFATE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIMETHYL SULFOXIDE; DRAGON BALM; GINGER EXTRACT; GLUCOCORTICOID; GLUCOSAMINE SULFATE; HERBACEOUS AGENT; HYALURONIC ACID; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MINERAL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; PENNSAID; PEPPERMINT OIL; PIROXICAM; PLACEBO; PLANT EXTRACT; SALICYLIC ACID DERIVATIVE; TENOXICAM; TIGER BALM; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN;

ACUPUNCTURE; AEROBIC EXERCISE; ANALGESIA; ANGIONEUROTIC EDEMA; BURNING SENSATION; CARDIOVASCULAR RISK; CHINESE MEDICINE; CLINICAL TRIAL; CONSTIPATION; DERMATITIS; DIARRHEA; DIET THERAPY; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG SYNOVIAL FLUID LEVEL; DRUG TISSUE LEVEL; DRUG TRANSPORT; DRUG WITHDRAWAL; DRY SKIN; DYSPEPSIA; EPIGASTRIC PAIN; ERYTHEMA; FUNCTIONAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HEALTH PROGRAM; HEART FAILURE; HIP OSTEOARTHRITIS; HUMAN; HYPERTENSION; JOINT INSTABILITY; JOINT SURGERY; KIDNEY FAILURE; KNEE OSTEOARTHRITIS; LEG EDEMA; LOW LEVEL LASER THERAPY; MAXIMUM PLASMA CONCENTRATION; MEDICINAL PLANT; MELENA; META ANALYSIS; MONOTHERAPY; NAUSEA; OSTEOARTHRITIS; PARESTHESIA; PATIENT EDUCATION; PEPTIC ULCER; PRIORITY JOURNAL; PRURITUS; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN IRRITATION; SKIN REDNESS; SOCIAL SUPPORT; SYSTEMATIC REVIEW; TRANSCUTANEOUS NERVE STIMULATION; VOMITING; WEIGHT REDUCTION; XEROSTOMIA;

EID: 34249312648     PISSN: 17460816     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460816.2.2.163     Document Type: Review

References (75)

1. Hunter DJ, Felson DT: Osteoarthritis. Br. Med. J. 332(7542), 639-642 (2006).
2. Cooper C, Jordan KM: Topical NSAIDs in osteoarthritis. Br. Med. J. 329(7461), 304-305 (2004).
3. Tugwell PS, Wells GA, Shainhouse JZ: Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J. Rheumatol. 31(10), 2002-2012 (2004).
4. Bird HA: When are NSAIDs appropriate in osteoarthritis? Drugs Aging 12(2), 87-95 (1998).
5. Sarzi-Puttini P, Cimmino MA, Scarpa R et al.: Osteoarthritis: an overview of the disease and its treatment strategies. Semin. Arthritis Rheum. 35(1 Suppl. 1), 1-10 (2005).
6. Lawrence RC, Helmick CG, Arnett FC et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41(5), 778-799 (1998).
7. Creamer P, Hochberg MC: Osteoarthritis. Lancet 350(9076), 503-508 (1997).
8. Felson DT: Clinical practice. Osteoarthritis of the knee. N. Engl. J. Med. 354(8), 841-848 (2006).
9. Messier SP, Loeser RF, Mitchell MN et al.: Exercise and weight loss in obese older adults with knee osteoarthritis: a preliminary study. J. Am. Geriatr. Soc. 48(9), 1062-1072 (2000).
10. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 43(9), 1905-1915 (2000).
11. Ge Z, Mu Y, Heng BC et al.: Osteoarthritis and therapy. Arthritis Rheum. 55(3), 493-500 (2006).
12. Scharf HP, Mansmann U, Streitberger K et al.: Acupuncture and knee osteoarthritis: a three-armed randomized trial. Ann. Intern. Med. 145(1), 12-20 (2006).
13. Kwon YD, Pinter MH, Ernst E: Acupuncture for peripheral joint osteoarthritis: a systematic review and meta-analysis. Rheumatology (Oxford), 45(11), 1331-1337 (2006).
14. Chen LX, Goldman J, Pullman-Mooar S. Therapy for Chronic Pain. In: The Textbook of Fibromyalgia and Other Non-Neuropathic Pain Syndromes. Wallace D, Clauw D (Eds): Lippincott Williams & Wilkins, PA, USA (2005).
15. Litt JZ: Alternative topical therapy. Dermatol Clin. 7(1), 43-52 (1989).
16. Zizeng L, Shude J: Applied traditional Chinese medicine in rheumatism. Beijing: Peoples' Health (1998).
17. Ng SK: Topical traditional Chinese medicine. A report from Singapore. Arch. Dermatol. 134(11), 1395-1396 (1998).
18. Zhang W, Jones A, Doherty M: Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann. Rheum. Dis. 63(8), 901-907 (2004).
19. Bjordal JM, Ljunggren AE, Klovning A, Slordal L: Non-steroidal and-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. Br. Med. J. 329(7478), 1317(2004).
20. Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G: Acetaminophen for osteoarthritis. Cochrane Database Syst. Rev. (1), CD004257 (2006).
21. Bannwarth B: Acetaminophen or NSAIDs for the treatment of osteoarthritis. Best Pract. Res. Clin. Rheumatol 20(1), 117-129 (2006).
22. Glass GG: Osteoarthritis. Clin. Fam. Pract. 7, 161-179 (2005).
23. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY: Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch. Intern. Med. 163(13), 1514-1522 (2003).
24. Clegg DO, Reda DJ, Harris CL et al.: Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N. Engl. J. Med. 354(8), 795-808 (2006).
25. Jordan KM, Arden NK, Doherty M et al.: EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann. Rheum. Dis. 62(12), 1145-1155 (2003).
26. Arroll B, Goodyear-Smith F, Corticosteroid injections for osteoarthritis of the knee: meta-analysis. Br. Med. J. 328(7444), 869 (2004).
27. Ravaud P, Moulinier L, Giraudeau B et al.: Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum. 42(3), 475-482 (1999).
28. Raynauld JP, Buckland-Wright C, Ward R et al.: Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 48(2), 370-377 (2003).
29. Tannenbaum H, Bombardier C, Davis P, Russell AS; Third Canadian Consensus Conference Group: An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference. J. Rheumatol. 33(1), 140-157 (2006).
30. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ: Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. Br. Med. J. 316(7128), 333-338 (1998).
31. Griffin MR: Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am. J. Med. 104(3A), S23-S29 (1998).
32. Langman MJ: Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden? Pharmacoepidemiol. Drug Saf. 10(1), 13-19 (2001).
33. Fitzgerald GA: Coxibs and cardiovascular disease. N. Engl. J. Med. 351(17), 1709-1711 (2004).
34. Sift Carter R, Ebner D, Brenner D et al.: Use of topical NSAIDs in patients receiving systemic NSAID treatment: a pharmacy-based study in Germany. J. Clin. Epidemiol. 50(2), 217-218 (1997).
35. Mazieres B: Topical ketoprofen patch. Drugs R D 6(6), 337-344 (2005).
36. Lan Chen TA: Is there a role for topical nonsteroidal anti-inflammatory drugs in the treatment of tendonitis? Aging Health 2(1), 59-60 (2006).
37. Dehghanyar P, Mayer BX, Namiranian K, Mascher H, Muller M, Brunner M: Topical skin penetration of diclofenac after single- and multiple-dose application. Int. J. Clin. Pharmacol. Ther. 42(7), 353-359 (2004).
38. Heyneman CA, Lawless-Liday C, Wall GC: Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 60(3), 555-574 (2000).
39. Vaile JH, Davis P: Topical NSAIDs for musculoskeletal conditions. A review of the literature. Drugs 56(5), 783-799 (1998).
40. Bouchier-Hayes TA, Rotman H, Darekar BS: Comparison of the efficacy and tolerability of diclofenac gel (Voltarol Emulgel) and felbinac gel (Traxam) in the treatment of soft tissue injuries. Br. J. Clin. Pract. 44(8), 319-320 (1990).
41. Bookman AA, Williams KS, Shainhouse JZ: Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 171(4), 333-338 (2004).
42. Rolf C, Engstrom B, Beauchard C, Jacobs LD, Le Liboux A: Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Rheumatology (Oxford) 38(6), 564-567 (1999).
43. Dominkus M, Nicolakis M, Kotz R, Wilkinson FE, Kaiser RR, Chlud K: Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittelforschung 46(12), 1138-1143 (1996).
44. Subramanian N, Ghosal SK, Moulik SP: Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Drug Dev. Ind. Pharm. 31(4-5), 405-416 (2005).
45. Paolino D, Ventura CA, Nistico S, Puglisi G, Fresta M: Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int. J. Pharm. 244(1-2), 21-31 (2002).
46. Yang JH, Kim YI, Kim KM: Preparation and evaluation of aceclofenac microemulsion for transdermal delivery system. Arch. Pharm. Res. 25(4), 534-540 (2002).
47. Yuan Y, Li SM, Mo FK, Zhong DF: Investigation of microemulsion system for transdermal delivery of meloxicam. Int. J. Pharm. 321(1-2), 117-123 (2006).
48. Rosenstein ED: Topical agents in the treatment of rheumatic disorders. Rheum. Dis. Clin. North Am. 25(4), 899-918, viii (1999).
49. Sandelin J, Harilainen A, Crone H, Hamberg P, Forsskahl B, Tamelander G: Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel. Scand J. Rheumatol. 26(4), 287-292 (1997).
50. Roth SH, Shainhouse JZ: Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch. Intern. Med. 164(18), 2017-2023 (2004).
51. Welch V, Brosseau L, Peterson J, Shea B, Tugwell P, Wells G: Therapeutic ultrasound for osteoarthritis of the knee. Cochrane Database Syst. Rev. (3), CD003132 (2001).
52. Speed CA: Therapeutic ultrasound in soft tissue lesions. Rheumatology (Oxford) 40(12), 1331-1336 (2001).
53. Gam AN, Johannsen F: Ultrasound therapy in musculoskeletal disorders: a meta-analysis. Pain 63(1), 85-91 (1995).
54. Cordero, JA, Camacho M, Obach R, Domenech J, Vila L: In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur. J. Pharm. Biopharm. 51(2), 135-142 (2001).
55. Yano T, Nakagawa A, Tsuji M, Noda K: Skin permeability of various non-steroidal anti-inflammatory drugs in man. Life Sci. 39(12), 1043-1050 (1986).
56. Waikakul S, Penkitti P, Soparat K, Boonsanong W: Topical analgesics for knee arthrosis: a parallel study of ketoprofen gel and diclofenac emulgel. J. Med. Assoc. Thai. 80(9), 593-597 (1997).
57. Patel RK, Leswell PF: Comparison of ketoprofen, piroxicam, and diclofenac gels in the treatment of acute soft-tissue injury in general practice. General Practice Study Group. Clin. Ther. 18(3), 497-507 (1996).
58. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ: Topical NSAIDs for acute pain: a meta-analysis. BMC Fam. Pract. 5, 10 (2004).
59. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ: Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet. Disord. 5, 28 (2004).
60. Niethard FU, Gold MS, Solomon GS et al.: Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J. Rheumatol. 32(12), 2384-2392 (2005).
61. Baer PA, Thomas LM, Shainhouse Z: Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet. Disord. 6, 44 (2005).
62. Trnavsky K, Fischer M, Vogtle-Junkert U, Schreyger F: Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study. J. Rheumatol. 31(3), 565-572 (2004).
63. Giamberardino MA: Proof of the pharmacodynamic activity of Flector Plaster in healthy volunteers and patients suffering from osteoarthritis of the knee. Presse Med. (33), 355-359 (2004).
64. Bruhlmann, P, Michel BA: Topical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Clin. Exp. Rheumatol. 21(2), 193-198 (2003).
65. Ottillinger B, Gomor B, Michel BA, Pavelka K, Beck W, Elsasser U: Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthr. Cartil. 9(3), 273-280 (2001).
66. Rovensky J, Micekova D, Gubzova Z et al.: Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug. Results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5% ibuprofen cream. Drugs Exp. Clin. Res. 27(5-6), 209-221 (2001).
67. Grace D, Rogers J, Skeith K, Anderson K: Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee. J. Rheumatol. 26(12), 2659-2663 (1999).
68. Roth SH: A controlled clinical investigation of 3% diclofenac/2.5% sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with osteoarthritis. Int. J. Tissue React. 17(4), 129-132 (1995).
69. Dreiser RL, Tisre-Camus M: DHEP plasters as a topical treatment of knee osteoarthritis - a double-blind placebo-controlled study. Drugs Exp. Clin. Res. 19(3), 117-123 (1993).
70. Zacher J, Burger KJ, Farber L, Grave M, Abberger H, Bertsch K: Topical diclofenac versus oral ibuprofen: a double blind, randomized clinical trial to demonstrate efficacy and tolerability in patients with activated osteoarthritis of the finger joints (Heberden and/or Bouchard arthritis). Aktuelle Rheumatologie 26(1), 7-14 (2001).
71. Browning RC, Johson K: Reducing the dose of oral NSAIDs by use of Feldene Gel: an open study in elderly patients with osteoarthritis. Adv. Ther. 11(4), 198-207 (1994).
72. Dickson DJ: A double-blind evaluation of topical piroxicam gel with oral ibuprofen in osteoarthritis of the knee. Curr. Ther. Res. Clin. Exp. 49, 199-207 (1991).
73. Lin J, Zhang W, Jones A, Doherty M: Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. Br. Med. J. 329(7461), 324 (2004).
74. Biswal S, Medhi B, Pandhi P: Long-term efficacy of topical nonsteroidal antiinflammatory drugs in knee osteoarthritis: metaanalysis of randomized placebo controlled clinical trials. J. Rheumatol. 33(9), 1841-1844 (2006).
75. Bjordal JM, Klovning A, Ljunggren AE, Slordal L: Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur. J. Pain 11(2), 125-138 (2007).